Clinical Trial Update: Safety, Immunological Effect and Efficacy of the Combined Application of MPL and Grass Pollen Allergen [Phase 1]

View source ↗

Summary

This Phase 1 trial assesses the safety, immunological effects, and potential efficacy of combining MPL adjuvant with a grass pollen allergen for Type I hypersen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Grass Pollen Allergy
• Hay Fever

Drugs mentioned

• Grass pollen allergen extract (Grass pollen allergen extract)
• Monophosphoryl lipid A (MPL) adjuvant (Monophosphoryl lipid A)

Snippet

Sponsor: Allergy Therapeutics | Conditions: Type I Hypersensitivity | Phase 1 | Status: COMPLETED